重新审查澳大利亚监狱中强制性药物检测
Jocelyn Chan1,2, Mark Stoové1,3, Jon Cook2,3
1Disease Elimination Program, Burnet Institute, Melbourne, Australia.
Drug and alcohol review
|July 7, 2024
概括
澳大利亚监狱中的强制性药物检测证据有限,支持其有效性,可能会造成伤害. 本评论回顾了证据,并建议药物监督的降低危害策略.
科学领域:
- 犯罪学 犯罪学
- 公共卫生 公共卫生
- 法医科学 法医科学 法医科学
背景情况:
- 强制性药物检测是澳大利亚惩戒设施中普遍存在的策略.
- 主要目标是检测和阻止监狱人口中的非法物质使用.
研究的目的:
- 批判性地评估监狱中强制性药物检测计划的现有证据基础.
- 识别和讨论与这些计划相关的潜在不利后果和危害.
- 提出与危害最小化框架一致的替代药物监测建议.
主要方法:
- 关于在惩戒机构中强制性药物测试研究的文献综述.
- 对潜在危害的分析,包括道德考虑和对康复的影响.
- 根据减少危害的原则制定建议.
主要成果:
- 支持强制性药物测试在减少监狱中使用毒品方面的有效性证据有限且不确.
- 这些计划的实施可能会导致意想不到的负面后果,例如增加耻辱和减少信任.
- 现有的计划可能无法充分解决监狱环境中的毒品使用的复杂性.
结论:
- 需要重新评估澳大利亚监狱对强制性毒品测试的依赖.
- 药物监控战略应优先考虑减少危害,基于证据的做法,以及被监禁人员的福祉.
- 专注于治疗和支持的替代或补充方法可能更有效.
相关概念视频
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
150
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
150
Drug Elimination by Renal Route: Tubular Reabsorption
3.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K
Drug Elimination by Renal Route: Tubular Secretion
2.3K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.3K
Drug Elimination: Non-Renal Routes
2.3K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.3K
Drug Elimination by Renal Route: Glomerular Filtration
5.6K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
5.6K


